Background and purpose: Lung cancer is the most common cause of cancer death in both men (30%) and women (26%) in the United States and world. Five-year survival rate of all patients with lung cancer ranges from 13% to 18% [1]; however, early detection and resection at Stage I tumor of less than 20 mm in size, the 5-year survival rate is as high as 70-75% [2]. Dynamic contrast CT, positron emission tomography (PET), and dynamic contrast enhanced (DCE) MRI are examples of the non-invasive techniques. While each technique gives a certain level of reliable results to diagnose a malignant solitary pulmonary nodule (SPN), DCE-MRI offers a radiation-free non-invasive option to the patients. Recent advances in MRI technology made lung imaging much more acceptable and desirable for detailed analysis. Several studies have been published on DCE-MRI in lung cancer discussing diagnostic role of perfusion indices [3]; however, very little has been investigated on pharmacokinetic parameters, such as trans-endothelial transfer constant (K
Background and purpose: Lung cancer is the most common cause of cancer death in both men (30%) and women (26%) in the United States and world. Five-year survival rate of all patients with lung cancer ranges from 13% to 18% [1] ; however, early detection and resection at Stage I tumor of less than 20 mm in size, the 5-year survival rate is as high as 70-75% [2] . Dynamic contrast CT, positron emission tomography (PET), and dynamic contrast enhanced (DCE) MRI are examples of the non-invasive techniques. While each technique gives a certain level of reliable results to diagnose a malignant solitary pulmonary nodule (SPN), DCE-MRI offers a radiation-free non-invasive option to the patients. Recent advances in MRI technology made lung imaging much more acceptable and desirable for detailed analysis. Several studies have been published on DCE-MRI in lung cancer discussing diagnostic role of perfusion indices [3] ; however, very little has been investigated on pharmacokinetic parameters, such as trans-endothelial transfer constant (K trans ), extravascular extracellular volume fraction (v e ) and k ep (K trans /v e ) [4] . In this study, we discuss clinical application of pharmacokinetic analysis as a biomarker in diagnosis of malignant SPNs. Materials and Methods: Thirty-four patients (9 males, 25 females, 26-87 years old, average 65 years old) with a SPN between15 to 30mm entered this study. The study was conducted under the guideline of the Internal Review Board and a written informed consent was obtained from all the participants. The initial diagnosis of SPN was made by CT and chest x-ray, and all patients underwent MRI study including T2-weighted axial half-Fourier acquisition single-shot turbo spin-echo (HASTE) images, pre and post contrast T1-weighed axial, sagittal, and coronal volumetric interpolated breath-hold examination (VIBE) images, and 2D turbo FLASH perfusion imaging. The perfusion study was performed with shallow free breathing. All MRI studies were performed on a 3T-superconducting magnet (Siemens Trio, TIM system, Erlangen, Germany) using a body array coil. After the imaging study, histological diagnoses were made in 30 SPNs (4 SPNs were considered clinically benign and followed by CT). MRI parameters were as follows: T2-weighted HASTE (TR/TE=1200/100msec, FOV=400mm, 320x320, 1 excitation, BW=780kHz, FA=150, ETL=256, 5.5mm slice thickness/1.6mm inter slice gap, scan time=6min); T1-weighted VIBE (TR/TE=3.4/1.3msec, FOV=400mm, 260x320, 1 excitation, BW=505kHz, FA=10, 4mm slice thickness/0mm inter slice gap, scan time=1.7min); turbo FLASH (TR/TE=500/1.6msec, FOV=400mm, 192x180, 1 excitation, BW=360kHz, FA=10, 5mm slice thickness, oblique sagittal orientation, Temporal resolution=2sec, 124 frames, scan time=4min, Gd-DTPA iv. 0.1 mmol/kg). B-spline non-rigid image registration and Chi-square optimization were performed on DCE-MRI to better calculate parameters [5] . Mean transit time (MTT), time-to-peak (TTP), initial slope (IS), and maximum enhancement (E max ) were calculated from time-intensity curves. Time-intensity curves were classified into 4 types (A-D) by three experienced radiologists, who evaluated these curves to diagnose malignant SPNs. K trans , v e , and k ep were calculated based on the two-compartment model [6] . After blinded data analysis, correlation with tissue histology, from the surgical resection was performed. Results: Of 30 patients, 27 underwent surgical resection, and 3 underwent CT-guided needle biopsy. The histology included 17 adenocarcinomas, 5 squamous cell carcinomas (SCC), 3 carcinoid tumors, 1 benign solitary fibrous tumor, 1 sclerosing pneumocytoma, 1 hamartoma, 1 reactive nodule, and 1 mycobacterial granuloma. Two out of 30 SPNs demonstrated Type A curve pattern (both malignant), 19 SPNs (2 benign and 17 malignant) showed Type B curve, 6 SPNs (1 benign and 5 malignant) showed Type C curve, and 3 SPNs (2 benign and 1 malignant) showed Type D curve. In predictive diagnosis of a malignant SPN by time intensity-curve pattern, where Type A considered most malignant and Type D considered most benign nature, made by 3 experienced radiologists, sensitivity ranged from 84-96%, specificity 50-80%, accuracy 83-90%, positive predictive value 92-96%, negative predictive values 50-75%. We analyzed each index and parameter value by histology type, malignant vs. benign. Average MTT was slightly higher in malignant SPNs than benign SPNs (p=0.037). Average TTP was slightly shorter in malignant SPNs than benign SPNs (p=0.011). Average IS was steeper (p=0.032) and E max was larger (not statistically significant, p=0.062) in malignant SPNs than benign SPNs. , MTT and IS, significant lower value in TTP compared with benign tumors. However, individual value of these parameters and indices showed many overlapping values in malignant and benign tumors and their histology could not be separated by those values. On the other hand, k ep distinguished malignant from benign tumors most accurately. The large majority (84%) of malignant tumors showed a k ep value greater than 0.90 min -1 with few exceptions, while all benign tumors showed equal or less than 0.90 min -1 . Four SPNs that showed k ep of less than 0.90 min -1 included a poorly differentiated SCC, two acinar-pattern adenocarcinomas, and a mixed-type adenocarcinoma with 50% acinar component and as little as 10% of solid component. Possibility of more acinar component than solid component in the tumor to result in lower perfusion, thus relatively lower K trans and k ep less than 0.90min -1 may be one explanation; however, many other adenocarcinomas with similar histology also had k ep value of greater than 0.90min -1 . The same was true with SCC. Therefore, we may only be able to assume that these 4 malignant tumors with k ep less than 0.90min -1 happened to have very low vascularity and permeability regardless of their cellular histology. The average size of these tumors was 18.5mm (ranged from 17-21mm). On the other hand, the average size of 21 malignant SPNs with kep>0.90min -1 was 20.4mm (range from 19-28mm), which was larger than the ones with k ep <0. 
